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Abstract
Over the last decade or so, stent implantation to the arterial duct has achieved acceptance as an
alternative to aortopulmonary shunt procedure. We present the case of a patient with tetralogy of
Fallot with diminished pulmonary flow and complete proximal occlusion of a right-sided Blalock-
-Taussig shunt. Surgical repair was not possible because of relative contraindications, and the
interventional shunt recanalisation attempt was unsuccessful. The coronary stent was im-
planted into arterial duct. This resulted in oxygen saturation increase with normal contrast
flow to the left pulmonary artery and right pulmonary artery (prior to the procedure we
suspected non-confluent pulmonary artery). This brief report evaluates the feasibility of this
new therapeutical option in such special patients with duct-dependent pulmonary blood flow.
(Cardiol J 2011; 18, 1: 87–89)
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Case report
A premature male, born during the thirty-fourth
week of gestation, with birth weight of 2,700 g, had
been diagnosed as having trisomia 21 and tetralogy
of Fallot with duct-dependent pulmonary circula-
tion. The patient was supported with continuous in-
fusion of prostaglandins (alprostadil at a dose of 0.02
mg/kg/min) and mechanical ventilation, and was treat-
ed for thrombocytopenia. After 50 days of life, he un-
derwent placement of a right modified Blalock-Taus-
sig shunt (diameter 3.5 mm). Two weeks later, the
patient was referred to our clinic with cyanosis and
symptoms of infection (Pseudomas aeruginosa sepsis).
He developed severe hypoxia with oxygen saturation
decreased to 50–60%. Echocardiography revealed the
small patent arterial duct with low velocity shunting
and non-confluent left and right pulmonary arteries.
The right-sided shunt was not visualized (Fig. 1).
The emergency catheterization was performed
under general anesthesia with mechanical ventila-
tion; a single-plane Philips Integris CV angiograph
was employed. The patient was treated with intra-
venous meropenem 20 mg/kg/dose according to an-
tibiogram. Stent implantation into arterial duct (AD)
was an emergency, life-saving procedure, so we de-
cided to perform it, despite the risk of endocarditis.
We used the femoral artery approach (4 F
sheath). Heparin was administered intravenously
(100 units per kg of body weight) after cannulation
of the femoral artery. Angiography through a diag-
nostic 4 F Judkins catheter inserted into the sub-
clavian artery was performed. Tissue plasminogen
activator (actilyse) was not administered.
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Than we performed a selective angiography
from the proximal part of the left-sided arterial duct.
We noticed critical tubular duct stenosis (Fig. 2),
and there was no contrast medium flow and com-
munication between the left and the right pulmo-
nary artery. We gently passed through the duct
a soft coronary wire 0.014” and stabilized the distal
tip in a left lower pulmonary branch. The balloon
expandable low profile coronary stent (3.5 × 15 mm
Chopin II manufactured by Balton, Warsaw, Poland)
was delivered uncovered to the distal pulmonary
circulation via a short vascular sheath (Fig. 3). The
position of the stent prior to deployment was con-
firmed by comparison to a digital freeze frame of ini-
tial angiograms (the method described by Pass [1]).
The position of the implanted AD stent is very
important. We were trying to position the stent
without changing the position of the angiographic
table towards the radiographic lamp. This method
allows only for approximate localization of the stent
in arterial duct. An alternative (and more popular)
method is to use a long vascular sheath or guiding
catheter and perform an angiography in ductal ori-
fice for exact localization of the stent in AD. How-
ever, this technique requires an arterial sheath of
a larger diameter (5 F minimum), which can be
a technical problem in infants and small children.
In our case, stent implantation into AD was a ‘quick
palliation’ for the patient’s condition, a means of
stabilization before qualifying for total surgical cor-
rection.
The stent was implanted more distally than
usual because we suspected non-confluent left pul-
monary artery (LPA) and right pulmonary artery
(RPA). The external diameter of the stent was not
oversized and was compatible with the proximal
duct diameter. On the final aortography we noticed
normal, non-restrictive contrast medium flow to left
and right pulmonary artery (Fig. 4). Oxygen satu-
ration increased from 65% to 91%. Four hours af-
ter completion of the procedure, 1 mg/kg of body
weight low-molecular weight heparin (enoxaparin
sodium-clexane) was administered subcutaneous-
ly and the patient was then maintained on oral ace-
tylsalicylic acid 3 mg/kg of body weight once daily.
Figure 1. Angiographic view of the occluded right-
-sided Blalock-Taussing shunt.
Figure 3. Fluoroscopy: positioning the flexible, pre-mo-
unted coronary stent into the duct.
Figure 2. Angiographic view of the stenotic left-sided
arterial duct.
89
Tomasz Moszura et al., Emergency duct stenting
www.cardiologyjournal.org
Discussion
Arterial duct stenting in neonates with cyanot-
ic congenital heart defects and duct-dependent pul-
monary flow has been reported in many papers [2–
–6]. It has been proposed as an attractive alternative
to the surgical shunt. According to the latest data
published by Santoro and Palladino, such a procedure
seems to be better than classic Blalock-Taussig anas-
tomosis in avoiding any imbalance of lung perfusion
with an increase of McGoon and Nakata indices [6].
In common with most interventional cardiolo-
gists, we prefer a pre-mounted coronary, flexible
and low profile stent to stabilize the duct [3, 4]. The
stent should cover the complete length of the duct
[7]. The implantation procedure was performed
without using a long vascular sheath.
We decided to implant the stent more distally than
usual [7] due to specific anatomy:non confluent left and
right pulmonary arteries (probably occlusion of the
proximal LPA by ductal tissue) [8] and right-sided aor-
tic arch. In our case, modified Blalock-Taussig shunt
occlusion resulted in a sudden reduction of pulmonary
vascular perfusion, causing a dramatic saturation de-
crease, cyanosis and deterioration in the patient’s con-
dition. This posed a direct threat to the child’s life, so
a coronary stent implantation to the critically narrowed
duct was the rescue emergency procedure we chose.
The access and position of the stent was easily
achieved, with fluoroscopy time of 4.2 min.
Although some patients will need repeated car-
diac catheterizations with subsequent stent re-di-
latations due to intima proliferation, this procedure
is worth considering [4–6, 9–11]. The latest data
shows the benefit of using ropamicin-eluting stents
(DES) for maintaining patency in critically duct-
-dependent patients [12].
In our case, the proximal part of LPA was prob-
ably tapered and covered by the ductal tissue, as in
the histological examination published by Eizenga
[13]. It might discontinue the pulmonary artery
flow, and significantly increases the risk of total cor-
rection of tetralogy of Fallot.
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Figure 4. Contrast medium flow after the stent implan-
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